Joe Wilson is the COO of Mothership Lab and was previously the COO & Co-Founder of MultiplyLabs (a Y-Combinator company). He has studied at MIT and Duke and shares his thoughts on developing new drug delivery methods.

Dr. Michael Weaver is the medical director of the Center for Neurobehavioral Research on Addictions at the University of Texas. As an addiction specialist, he has over 20 years of experience in treating patients with addiction in a variety of medical settings.

Catharine Dockery is founder of Vice Ventures, a venture capital firm that specializes in investing in companies typically thought of to be operating in "vice" categories like cannabis, gambling and alcohol.

Joe Angiuli is a Vice President at First Beverage Ventures. He is involved with deal origination and execution across alcoholic and non-alcoholic beverage transactions for the private equity team at First Beverage.

Weston Nichols is a biotech analyst at Perceptive Advisors. He earned his Ph.D. in neuroscience from Caltech, and undergraduate degree in biological engineering from Cornell.

Heath Evans is a former American football fullback and former analyst on NFL Network. He joins us to discuss how steroids and other drugs are treated in the NFL and broader athletic community along with how these perceptions and rules have changed over the past years.

Kristi Knoblich Palmer is the co-founder of Kiva Confections, one of California's most successful and recognizable cannabis edibles brands.

Hamilton Morris is a journalist, pharmacologist, and researcher who investigates the chemistry, effects and history of various psychoactive drugs.

Dr. Sherman's work over the last two decades has focused on innovative ways to reach and deliver tobacco use cessation treatment within health care, particularly to populations with low rates of treatment.

The Lucy co-founders discuss the genesis of the new company and why they are excited to make this product available to everyone.